Home / Health / Maharashtra FDA Cracks Down on Supplement Claims
Maharashtra FDA Cracks Down on Supplement Claims
21 Nov
Summary
- Maharashtra FDA issued new regulations for health and nutraceutical supplements.
- Misleading claims and medical endorsements are now prohibited for supplements.
- Online sellers and supply chains face stricter scrutiny and compliance.
The Maharashtra Food and Drug Administration (FDA) has implemented a comprehensive compliance order to regulate the nutraceuticals and health supplements industry. This directive aims to curb misleading advertisements and influencer promotions prevalent on social media.
The new regulations ban the use of 'ORS' in product names and prohibit claims of treating or preventing diseases. Marketing terms like 'doctor-recommended' and the use of physician images are now disallowed across all advertising platforms.
The FDA will conduct a special enforcement drive targeting sports nutrition, weight-loss, sexual wellness, and herbal products suspected of containing undeclared steroids or pharmaceutical substances. Manufacturers must ensure products do not contain ingredients rejected by FSSAI or substances banned by WADA for sportspersons.
This order impacts the entire supply chain, including manufacturers, importers, retailers, and e-commerce platforms. Pharmacies and fitness centers selling these products must obtain valid FSSAI licenses. Strict labeling requirements and penalties, including stock seizure and criminal prosecution, will be enforced for violations.
In a related incident on November 13, the FDA seized stocks worth ₹1.39 crore containing unapproved ingredients. Consumers are advised to purchase supplements from licensed outlets and check labels carefully, avoiding products with unsubstantiated claims.